Is Cold Chain Bleeding Your Lab Dry?

Card image cap
Nov 09, 2020 · By Lenny
A cold chain is a temperature-controlled supply chain that includes all vaccine-related equipment and procedures. The cold chain begins with the cold storage unit at the manufacturing plant, extends to the transport and delivery of specimen and proper storage at the provider facility, and ends with diagnosis of the patient.

Manufacturers, distributors, public health staff, health care providers, and laboratories share responsibility to ensure the specimen cold chain is maintained from the time the sample is collected, until a diagnosis is delivered to the patient.

But at what cost to the labs and physicians?

Cold Chain collection and transport is expensive and has become increasingly difficult in delivering an accurate diagnosis to the patient. Not only does this inefficiency hurt the bottom line of labs and providers, but also has the potential to hurt patient by misdiagnosis and downstream medical problems.

To mitigate the cost ($137 - $276) in cold chain transport, labs must consider optimizing the areas of sample collection and transport that are bleeding them dry:

·         Refrigeration

·         Ice Packs

·         Temperature regulated storage bins

·         Insulated shipping units

·         Refrigerated ground transportation

·         Refrigerated air transportation

·         Rush shipping orders

To discuss cold chain costs and related topics, click here:

Leonard (Lenny) founded Vax-Immune in 2015 with a vision to innovate how we diagnose infectious diseases. As a neonatologist for 40 years, Lenny watched babies die due to misdiagnosis and after realizing that the problem lay in the way samples were being transported, “retired" to develop the first specimen transport system with specimen multiplier technology, eliminating the need for traditional transport and preventing misdiagnosis. The son of Holocaust survivors, Lenny was born in a displaced persons camp in Germany, came to America and went on to graduate from West Point. After completing Airborne, Ranger and Air Defense Artillery schools, he served 24 years in the Army as an academic neonatologist, where he discovered and developed the breakthrough drug for Medimmune, which sold to Astra Zeneca for $15B. After retiring from the Army, Lenny joined the faculty at Baylor College of Medicine where he served as the Chief, Newborn Service, Texas Children’s Hospital, where his vision to build a women’s hospital became the Women’s Pavilion. While at TCH, he spearheaded the birth and care of the world’s first surviving set of octuplets and was featured in The New York Times, CNN, Today Show and in the international media.

By navigating this website, you agree to our Cookie Policy
LabReady | Logo